Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants - PubMed (original) (raw)
Comparative Study
. 2006 May 23;1(4):235-51.
doi: 10.1021/cb600187q.
Affiliations
- PMID: 17163678
- DOI: 10.1021/cb600187q
Comparative Study
Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants
Anu R Sawkar et al. ACS Chem Biol. 2006.
Abstract
Point mutations in the lysosomal hydrolase, glucocerebrosidase (GC), can cause Gaucher disease, a common lysosomal storage disease. Several clinically important GC mutations impede folding in the endoplasmic reticulum (ER) and target these enzymes for ER-associated degradation (ERAD). The removal of these misfolded proteins decreases the lysosomal concentration of GC, which results in glucosylceramide accumulation. The most common GC variant, N370S, and other clinically relevant variants, G202R and L444P, exhibit different cellular localization patterns in patient-derived fibroblasts. We show that these distributions can be altered by manipulation of the ER folding environment, either by chemical chaperones or by temperature shifts. N370S, L444P, and G202R GC are destabilized in the neutral pH environment of the ER, rendering them prone to ERAD. Fibroblasts harboring the G202R and L444P GC mutations grown at 30 degrees C localize the mutant proteins to the lysosome, and this increases total GC activity. Both of these temperature-sensitive mutants appear to be stable at 37 degrees C once they are trafficked to the low pH environment of the lysosome. Chemical chaperones correct the ER instability and significant ER retention of G202R GC. N370S is also destabilized under ER simulating conditions, a deficiency that is corrected by chemical chaperone binding. These data clearly show manipulating the ER environment with chemical chaperones increases the lysosomal concentration of partially active GC variants and suggest that small molecules could be used to treat Gaucher disease.
Comment in
- Reclamation of proteins from the cellular scrap heap.
Gestwicki JE. Gestwicki JE. ACS Chem Biol. 2006 May 23;1(4):201-3. doi: 10.1021/cb6001784. ACS Chem Biol. 2006. PMID: 17163671 Review.
Similar articles
- Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
Schmitz M, Alfalah M, Aerts JM, Naim HY, Zimmer KP. Schmitz M, et al. Int J Biochem Cell Biol. 2005 Nov;37(11):2310-20. doi: 10.1016/j.biocel.2005.05.008. Int J Biochem Cell Biol. 2005. PMID: 15982918 - Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Sawkar AR, Adamski-Werner SL, Cheng WC, Wong CH, Beutler E, Zimmer KP, Kelly JW. Sawkar AR, et al. Chem Biol. 2005 Nov;12(11):1235-44. doi: 10.1016/j.chembiol.2005.09.007. Chem Biol. 2005. PMID: 16298303 - Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts.
Wang F, Agnello G, Sotolongo N, Segatori L. Wang F, et al. ACS Chem Biol. 2011 Feb 18;6(2):158-68. doi: 10.1021/cb100321m. Epub 2010 Nov 10. ACS Chem Biol. 2011. PMID: 21043486 - Gaucher disease.
Butters TD. Butters TD. Curr Opin Chem Biol. 2007 Aug;11(4):412-8. doi: 10.1016/j.cbpa.2007.05.035. Epub 2007 Jul 23. Curr Opin Chem Biol. 2007. PMID: 17644022 Review. - Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
Choy FY, Zhang W, Shi HP, Zay A, Campbell T, Tang N, Ferreira P. Choy FY, et al. Blood Cells Mol Dis. 2007 May-Jun;38(3):287-93. doi: 10.1016/j.bcmd.2006.11.003. Epub 2006 Dec 29. Blood Cells Mol Dis. 2007. PMID: 17196853 Review.
Cited by
- Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis.
Ong DS, Mu TW, Palmer AE, Kelly JW. Ong DS, et al. Nat Chem Biol. 2010 Jun;6(6):424-32. doi: 10.1038/nchembio.368. Epub 2010 May 9. Nat Chem Biol. 2010. PMID: 20453863 Free PMC article. - Stability of the ABCD1 Protein with a Missense Mutation: A Novel Approach to Finding Therapeutic Compounds for X-Linked Adrenoleukodystrophy.
Morita M, Matsumoto S, Sato A, Inoue K, Kostsin DG, Yamazaki K, Kawaguchi K, Shimozawa N, Kemp S, Wanders RJ, Kojima H, Okabe T, Imanaka T. Morita M, et al. JIMD Rep. 2019;44:23-31. doi: 10.1007/8904_2018_118. Epub 2018 Jun 21. JIMD Rep. 2019. PMID: 29926352 Free PMC article. - Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification.
Keyzor I, Shohet S, Castelli J, Sitaraman S, Veleva-Rotse B, Weimer JM, Fox B, Willer T, Tuske S, Crathorne L, Belzar KJ. Keyzor I, et al. Biomolecules. 2023 Aug 7;13(8):1227. doi: 10.3390/biom13081227. Biomolecules. 2023. PMID: 37627292 Free PMC article. Review. - Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's disease.
Williams D, Glasstetter LM, Jong TT, Kapoor A, Zhu S, Zhu Y, Gehrlein A, Vocadlo DJ, Jagasia R, Marugan JJ, Sidransky E, Henderson MJ, Chen Y. Williams D, et al. bioRxiv [Preprint]. 2024 Mar 27:2024.03.22.586364. doi: 10.1101/2024.03.22.586364. bioRxiv. 2024. PMID: 38712038 Free PMC article. Preprint. - Restoration of proper trafficking to the cell surface for membrane proteins harboring cysteine mutations.
Lopez-Rodriguez A, Holmgren M. Lopez-Rodriguez A, et al. PLoS One. 2012;7(10):e47693. doi: 10.1371/journal.pone.0047693. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082193 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous